BofA Securities analyst Geoff Meacham reiterated a Buy rating and $80 price target on Bristol-Myers Squibb Co. (NYSE: BMY) into ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE